Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 29, 2017	Sep. 30, 2016
Current assets:
Cash and cash equivalents	$ 627,017	$ 516,112
Restricted cash	7,351	3,645
Short-term investments	247,757	121,629
Accounts receivable, net of allowance for doubtful accounts of $2,967 and $2,370	73,750	75,688
Inventories	25,051	16,354
Prepaid expenses and other current assets	30,508	26,302
Total current assets	1,011,434	759,730
Long-term investments	314,364	393,904
Property, plant and equipment, net	485,275	443,656
Intangible assets, net	189,648	215,342
Goodwill	311,087	309,616
Deferred taxes	190,915	166,790
Other non-current assets	30,831	21,068
Total assets	2,533,554	2,310,106
Current liabilities:
Accounts payable	14,373	17,544
Accrued liabilities	207,034	169,055
Income taxes payable	1,216	2,304
Deferred revenue	23,150	24,180
Total current liabilities	245,773	213,083
Long-term deferred revenue	36,425	35,366
Other non-current liabilities	107,514	82,922
Total liabilities	389,712	331,371
Stockholders' equity:
Additional paid-in capital	61,331	42,032
Retained earnings	2,083,063	1,938,320
Accumulated other comprehensive income	(7,753)	(10,197)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,136,742	1,970,256
Controlling interest	7,100	8,479
Total stockholders’ equity	2,143,842	1,978,735
Total liabilities and stockholders’ equity	2,533,554	2,310,106
Class A Common Stock [Member]
Stockholders' equity:
Common stock	58	57
Class B Common Stock [Member]
Stockholders' equity:
Common stock	$ 43	$ 44